TDR Targets

Basic information

Technical information

Name: Unnamed compound
MW: 655.717 | Formula: C32H42FN7O7
H donors: 4 H acceptors: 7 LogP: 5.08 Rotable bonds: 17
Rule of 5 violations (Lipinski): 2
SMILES: O=C(OC(C)(C)C)CCC(C(=O)OC(C)(C)C)Nc1ccc(cc1)CN(c1cc(F)ccc1[N+](=O)[O-])CCc1c(N)nc(nc1O)N
InChi: 1S/C32H42FN7O7/c1-31(2,3)46-26(41)14-12-23(29(43)47-32(4,5)6)36-21-10-7-19(8-11-21)18-39(25-17-20(33)9-13-24(25)40(44)45)16-15-22-27(34)37-30(35)38-28(22)42/h7-11,13,17,23,36H,12,14-16,18H2,1-6H3,(H5,34,35,37,38,42)
InChiKey: XJYPHZFNXOQNDC-UHFFFAOYSA-N

Network

Hover on a compound node to display the structore

Target Layer

Model Organisms

Species	Viewmode
Arabidopsis thaliana
Caenorhabditis elegans
Dictyostelium discoideum
Drosophila melanogaster
Escherichia coli
Homo sapiens
Mus musculus
Oryza sativa
Saccharomyces cerevisiae
Schmidtea mediterranea
Other organisms

TDR Pathogens:

Species	Viewmode
Brugia malayi
Chlamydia trachomatis
Echinococcus granulosus
Entamoeba histolytica
Echinococcus multilocularis
Giardia lamblia
Leishmania major
Loa Loa (eye worm)
Mycobacterium leprae
Mycobacterium tuberculosis
Mycobacterium ulcerans
Onchocerca volvulus
Plasmodium falciparum
Plasmodium vivax
Schistosoma mansoni
Trypanosoma brucei
Trypanosoma cruzi
Toxoplasma gondii
Treponema pallidum
Trichomonas vaginalis
Wolbachia endosymbiont of Brugia malayi

Other Pathogens:

Species	Viewmode
Babesia bovis
Candida albicans
Cryptosporidium hominis
Cryptosporidium parvum
Leishmania braziliensis
Leishmania donovani
Leishmania infantum
Leishmania mexicana
Neospora caninum
Plasmodium berghei
Plasmodium knowlesi
Plasmodium yoelii
Schistosoma japonicum
Trypanosoma brucei gambiense
Trypanosoma congolense
Theileria parva

Compound Layer

This is a work in progress. Come back soon to try this features!

Clustering layers

This is a work in progress. Come back soon to try this features!

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology

No druggable targets predicted by orthology data

By sequence similarity to non orthologous known druggable targets

No druggable targets predicted by sequence similarity

Ranking Plot

Putative Targets List

Species	Potential target	Raw	Global	Species
Trypanosoma cruzi	cysteine peptidase, putative	0.0211	1	1
Trichomonas vaginalis	Clan CA, family C1, papain-like cysteine peptidase	0.0211	1	1
Entamoeba histolytica	cysteine proteinase, putative	0.0211	1	1
Echinococcus granulosus	cathepsin b	0.018	0.6913	0.6913
Trichomonas vaginalis	Clan CA, family C1, papain-like cysteine peptidase	0.0211	1	1
Schistosoma mansoni	cathepsin F (C01 family)	0.0211	1	1
Trichomonas vaginalis	Clan CA, family C1, papain-like cysteine peptidase	0.0211	1	1
Onchocerca volvulus		0.0211	1	1
Entamoeba histolytica	cysteine proteinase, putative	0.0211	1	1
Brugia malayi	Cathepsin L-like precursor	0.0143	0.3182	0.3182
Echinococcus multilocularis	cathepsin l cysteine peptidase	0.0211	1	1
Trichomonas vaginalis	Clan CA, family C1, cathepsin L-like cysteine peptidase	0.0211	1	1
Loa Loa (eye worm)	fibroinase	0.0211	1	1
Leishmania major	cysteine peptidase A (CPA)	0.0211	1	0.5
Trichomonas vaginalis	Clan CA, family C1, cathepsin L-like cysteine peptidase	0.0211	1	1
Trichomonas vaginalis	Clan CA, family C1, cathepsin L-like cysteine peptidase	0.0143	0.3182	0.3182
Leishmania major	cathepsin L-like protease	0.0211	1	0.5
Schistosoma mansoni	cathepsin B-like peptidase (C01 family)	0.018	0.6913	0.6913
Trypanosoma brucei	cysteine peptidase, Clan CA, family C1, Cathepsin L-like	0.0211	1	1
Brugia malayi	Cathepsin L-like precursor	0.0211	1	1
Leishmania major	cathepsin L-like protease	0.0211	1	0.5
Echinococcus multilocularis	cathepsin b	0.018	0.6913	0.6913
Onchocerca volvulus		0.0211	1	1
Onchocerca volvulus	Cathepsin L homolog	0.0211	1	1
Trichomonas vaginalis	Clan CA, family C1, cathepsin L-like cysteine peptidase	0.0211	1	1
Schistosoma mansoni	cathepsin F (C01 family)	0.0211	1	1
Plasmodium falciparum	cysteine proteinase falcipain 2b	0.0211	1	1
Onchocerca volvulus		0.0211	1	1
Trypanosoma brucei	cysteine peptidase, Clan CA, family C1, Cathepsin L-like	0.0211	1	1
Onchocerca volvulus		0.0211	1	1
Trypanosoma brucei	cysteine peptidase, Clan CA, family C1, Cathepsin L-like	0.0211	1	1
Brugia malayi	cathepsin L-like precursor	0.0143	0.3182	0.3182
Trichomonas vaginalis	Clan CA, family C1, papain-like cysteine peptidase	0.0211	1	1
Trypanosoma brucei	cysteine peptidase, Clan CA, family C1, Cathepsin L-like	0.0211	1	1
Trichomonas vaginalis	Clan CA, family C1, papain-like cysteine peptidase	0.0211	1	1
Brugia malayi	Cathepsin L-like precursor	0.0211	1	1
Onchocerca volvulus		0.0211	1	1
Trypanosoma cruzi	cysteine peptidase C (CPC), putative	0.018	0.6913	0.6913
Plasmodium vivax	vivapain-2	0.0211	1	1
Trichomonas vaginalis	Clan CA, family C1, cathepsin L-like cysteine peptidase	0.0211	1	1
Onchocerca volvulus		0.0211	1	1
Loa Loa (eye worm)	ctsf protein	0.0211	1	1
Plasmodium falciparum	cysteine proteinase falcipain 3	0.0211	1	1
Trichomonas vaginalis	Clan CA, family C1, cathepsin L-like cysteine peptidase	0.0211	1	1
Echinococcus granulosus	cathepsin l1	0.0211	1	1
Echinococcus multilocularis	cysteine protease	0.0211	1	1
Trichomonas vaginalis	Clan CA, family C1, cathepsin L-like cysteine peptidase	0.0211	1	1
Echinococcus multilocularis	cysteine protease	0.0211	1	1
Brugia malayi	Cathepsin L-like precursor	0.0143	0.3182	0.3182
Trypanosoma brucei	cysteine peptidase, Clan CA, family C1, Cathepsin L-like	0.0211	1	1
Trypanosoma cruzi	cysteine peptidase, putative	0.0211	1	1
Brugia malayi	Cathepsin L-like precursor	0.0211	1	1
Entamoeba histolytica	cysteine proteinase, putative	0.0143	0.3182	0.3182
Brugia malayi	cathepsin B-like cysteine proteinase	0.018	0.6913	0.6913
Trypanosoma brucei	cysteine peptidase, Clan CA, family C1, Cathepsin L-like	0.0211	1	1
Trypanosoma cruzi	cruzipain precursor, putative	0.0211	1	1
Plasmodium falciparum	cysteine proteinase falcipain 2a	0.0211	1	1
Schistosoma mansoni	SmCB2 peptidase (C01 family)	0.018	0.6913	0.6913
Loa Loa (eye worm)	papain family cysteine protease containing protein	0.0211	1	1
Trypanosoma brucei	cysteine peptidase, Clan CA, family C1, Cathepsin L-like	0.0211	1	1
Schistosoma mansoni	cathepsin B-like peptidase (C01 family)	0.018	0.6913	0.6913
Trypanosoma brucei	cysteine peptidase, Clan CA, family C1, Cathepsin L-like	0.0211	1	1
Loa Loa (eye worm)	hypothetical protein	0.0211	1	1
Brugia malayi	Cathepsin L-like precursor	0.0211	1	1
Brugia malayi	Cathepsin L-like precursor	0.0211	1	1
Echinococcus multilocularis	cathepsin L cysteine protease	0.0211	1	1
Trichomonas vaginalis	Clan CA, family C1, cathepsin L-like cysteine peptidase	0.0211	1	1
Loa Loa (eye worm)	Papain cysteine protease/cathepsin propeptide inhibitor-containing protein	0.0211	1	1
Trypanosoma cruzi	cysteine peptidase, clan CA, family C1, cathepsin L-like, putative	0.0143	0.3182	0.3182
Trypanosoma cruzi	cysteine peptidase, putative	0.0211	1	1
Brugia malayi	Cathepsin L-like cysteine proteinase	0.0143	0.3182	0.3182
Trypanosoma brucei	cysteine peptidase, Clan CA, family C1, Cathepsin L-like	0.0211	1	1
Leishmania major	cathepsin L-like protease	0.0211	1	0.5
Trichomonas vaginalis	Clan CA, family C1, cathepsin L-like cysteine peptidase	0.0211	1	1
Leishmania major	cathepsin L-like protease	0.0211	1	0.5
Entamoeba histolytica	cysteine protease, putative	0.0211	1	1
Leishmania major	cathepsin L-like protease	0.0211	1	0.5
Echinococcus multilocularis	cathepsin l cysteine peptidase	0.0211	1	1
Echinococcus granulosus	cathepsin l1	0.0143	0.3182	0.3182
Trypanosoma brucei	cysteine peptidase, Clan CA, family C1, Cathepsin L-like	0.0211	1	1
Onchocerca volvulus		0.0211	1	1
Trichomonas vaginalis	Clan CA, family C1, cathepsin L-like cysteine peptidase	0.0211	1	1
Leishmania major	cathepsin L-like protease	0.0211	1	0.5
Schistosoma mansoni	cathepsin F (C01 family)	0.0143	0.3182	0.3182
Echinococcus multilocularis	cathepsin L cysteine protease	0.0211	1	1
Plasmodium vivax	vivapain-2	0.0211	1	1
Schistosoma mansoni	cathepsin B-like peptidase (C01 family)	0.018	0.6913	0.6913
Toxoplasma gondii	cathepsin CPL	0.0211	1	0.5
Trypanosoma brucei	cysteine peptidase, Clan CA, family C1, Cathepsin L-like	0.0211	1	1
Echinococcus granulosus	cathepsin l cysteine peptidase	0.0211	1	1
Brugia malayi	Papain family cysteine protease containing protein	0.0211	1	1
Leishmania major	cathepsin L-like protease	0.0211	1	0.5
Trichomonas vaginalis	Clan CA, family C1, cathepsin L-like cysteine peptidase	0.0211	1	1
Trichomonas vaginalis	Clan CA, family C1, papain-like cysteine peptidase	0.0211	1	1
Trichomonas vaginalis	Clan CA, family C1, cathepsin L-like cysteine peptidase	0.0211	1	1
Echinococcus granulosus	cathepsin L cysteine proteinase	0.0211	1	1
Trichomonas vaginalis	Clan CA, family C1, papain-like cysteine peptidase	0.0211	1	1
Onchocerca volvulus	Cathepsin L homolog	0.0211	1	1
Trypanosoma cruzi	cysteine peptidase, putative	0.0211	1	1
Leishmania major	cathepsin L-like protease	0.0211	1	0.5
Loa Loa (eye worm)	cysteine protease	0.0211	1	1
Trichomonas vaginalis	Clan CA, family C1, papain-like cysteine peptidase	0.0211	1	1
Echinococcus multilocularis	cathepsin b	0.018	0.6913	0.6913
Onchocerca volvulus	Cathepsin F homolog	0.0211	1	1
Loa Loa (eye worm)	hypothetical protein	0.018	0.6913	0.5472
Trichomonas vaginalis	Clan CA, family C1, cathepsin L-like cysteine peptidase	0.0211	1	1
Trichomonas vaginalis	Clan CA, family C1, cathepsin L or K-like cysteine peptidase	0.0211	1	1
Trichomonas vaginalis	Clan CA, family C1, cathepsin L-like cysteine peptidase	0.0143	0.3182	0.3182
Echinococcus granulosus	cathepsin b	0.018	0.6913	0.6913
Trichomonas vaginalis	Clan CA, family C1, papain-like cysteine peptidase	0.0211	1	1
Trichomonas vaginalis	Clan CA, family C1, cathepsin L-like cysteine peptidase	0.0211	1	1
Trichomonas vaginalis	Clan CA, family C1, cathepsin L or K-like cysteine peptidase	0.0211	1	1
Trichomonas vaginalis	Clan CA, family C1, cathepsin L-like cysteine peptidase	0.0211	1	1

Activities

Activity type	Activity value	Assay description	Source	Reference
IC50 (functional)	= 50 uM	Cytotoxicity in the presence of thymidine and hypoxanthine against CCRF-CEM cell line	ChEMBL.	10888335
IC50 (functional)	= 50 uM	Cytotoxicity in the presence of thymidine and hypoxanthine against CCRF-CEM cell line	ChEMBL.	10888335
IC50 (functional)	= 51 uM	Cytotoxicity in the absence of thymidine and hypoxanthine against CCRF-CEM cell line	ChEMBL.	10888335
IC50 (functional)	= 51 uM	Cytotoxicity in the absence of thymidine and hypoxanthine against CCRF-CEM cell line	ChEMBL.	10888335
IC50 (functional)	= 56 uM	Cytotoxicity in the absence of thymidine and presence of hypoxanthine against CCRF-CEM cell line	ChEMBL.	10888335
IC50 (functional)	= 56 uM	Cytotoxicity in the absence of thymidine and presence of hypoxanthine against CCRF-CEM cell line	ChEMBL.	10888335
IC50 (functional)	= 69 uM	Cytotoxicity in the absence of hypoxanthine and presence of thymidine against CCRF-CEM cell line	ChEMBL.	10888335
IC50 (functional)	= 69 uM	Cytotoxicity in the absence of hypoxanthine and presence of thymidine against CCRF-CEM cell line	ChEMBL.	10888335
Inhibition (binding)	%	In vitro inhibitory activity against Aminoimidazole carboxamide ribonucleotide transformylase pre-incubated for 12 hr at 250 microM; Not active.	ChEMBL.	10888335
Inhibition (binding)	NA 0 %	In vitro inhibitory activity against Aminoimidazole carboxamide ribonucleotide transformylase pre-incubated for 12 hr at 250 microM; Not active.	ChEMBL.	10888335
Inhibition (binding)	= 48 %	In vitro inhibitory activity against Glycinamide ribonucleotide transformylase (GAR Tfase) after 1 hr at 250 uM	ChEMBL.	10888335
Inhibition (binding)	= 48 %	In vitro inhibitory activity against Glycinamide ribonucleotide transformylase (GAR Tfase) after 1 hr at 250 uM	ChEMBL.	10888335
Inhibition (binding)	= 52 %	In vitro inhibitory activity against Glycinamide ribonucleotide transformylase (GAR Tfase) following 30 min pre-incubation at 250 microM concentration	ChEMBL.	10888335
Inhibition (binding)	= 52 %	In vitro inhibitory activity against Glycinamide ribonucleotide transformylase (GAR Tfase) following 30 min pre-incubation at 250 microM concentration	ChEMBL.	10888335
Inhibition (binding)	= 57 %	In vitro inhibitory activity against Glycinamide ribonucleotide transformylase (GAR Tfase+GAR) following 30 min pre-incubation at 250 microM concentration	ChEMBL.	10888335
Inhibition (binding)	= 57 %	In vitro inhibitory activity against Glycinamide ribonucleotide transformylase (GAR Tfase+GAR) following 30 min pre-incubation at 250 microM concentration	ChEMBL.	10888335
Inhibition (binding)	= 58 %	In vitro inhibitory activity against Glycinamide ribonucleotide transformylase (GAR Tfase+GAR) pre-incubation of 6 h at 250 microM concentration	ChEMBL.	10888335
Inhibition (binding)	= 58 %	In vitro inhibitory activity against Glycinamide ribonucleotide transformylase (GAR Tfase+GAR) pre-incubation of 6 h at 250 microM concentration	ChEMBL.	10888335
Inhibition (binding)	= 65 %	In vitro inhibitory activity against Glycinamide ribonucleotide transformylase (GAR Tfase) following 3 min pre-incubation at 250 microM concentration	ChEMBL.	10888335
Inhibition (binding)	= 65 %	In vitro inhibitory activity against Glycinamide ribonucleotide transformylase (GAR Tfase) following 3 min pre-incubation at 250 microM concentration	ChEMBL.	10888335
Inhibition (binding)	= 66 %	In vitro inhibitory activity against Glycinamide ribonucleotide transformylase (GAR Tfase+GAR) following 3 min pre-incubation at 250 microM concentration	ChEMBL.	10888335
Inhibition (binding)	= 66 %	In vitro inhibitory activity against Glycinamide ribonucleotide transformylase (GAR Tfase+GAR) following 3 min pre-incubation at 250 microM concentration	ChEMBL.	10888335

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

ChEMBL: CHEMBL287143

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.

Detailed information for compound 46303